NDC11 21922000221
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 21922-0002-21 | 21922-0002 |
| 21922-002-21 | 21922-002 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clindamycin Phoaphate Topical Solution USP, 1% | CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP, 1% | Encube Ethicals, Inc. | b2dfb76b-db09-43e7-8366-6791449a4918 | 2025-09-05 | Warnings, Adverse reactions | 21922-002-21 21922-002 21922000221 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.